These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19469650)

  • 1. How to search for specific markers of cancer stem cells.
    Liu HG; Zhang XH
    Asian Pac J Cancer Prev; 2009; 10(1):177-80. PubMed ID: 19469650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells.
    Cheung SK; Chuang PK; Huang HW; Hwang-Verslues WW; Cho CH; Yang WB; Shen CN; Hsiao M; Hsu TL; Chang CF; Wong CH
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):960-5. PubMed ID: 26677875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface markers of hepatocellular cancer stem cells and their clinical potential.
    Feng D; Wang N; Hu J; Li W
    Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells of the breast and cancer therapy.
    Groner B; Vafaizadeh V; Brill B; Klemmt P
    Womens Health (Lond); 2010 Mar; 6(2):205-19. PubMed ID: 20187727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic Implication Targeting for Cancer Stem Cells].
    Noguchi K; Konno M; Nishida N; Kawamoto K; Koseki J; Eguchi H; Doki Y; Mori M; Satoh T; Ishii H
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1036-9. PubMed ID: 26469158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sweet beginning for cancer stem cells.
    Baum LG
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):815-6. PubMed ID: 26772316
    [No Abstract]   [Full Text] [Related]  

  • 7. Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization.
    Sterlacci W; Savic S; Fiegl M; Obermann E; Tzankov A
    J Thorac Oncol; 2014 Jan; 9(1):41-9. PubMed ID: 24346092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of cancer stem cells: the role of self-renewal and differentiation.
    Wu XZ
    Ann Surg Oncol; 2008 Feb; 15(2):407-14. PubMed ID: 18043974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarker for Hematopoietic Tumors--Aiming for Personalized Diagnosis of Leukemia Stem Cells].
    Tohda S
    Rinsho Byori; 2015 Sep; 63(9):1110-3. PubMed ID: 26731901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines.
    Lobba AR; Forni MF; Carreira AC; Sogayar MC
    Cytometry A; 2012 Dec; 81(12):1084-91. PubMed ID: 23090904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer stem cells.
    Zeimet AG; Reimer D; Sopper S; Boesch M; Martowicz A; Roessler J; Wiedemair AM; Rumpold H; Untergasser G; Concin N; Hofstetter G; Muller-Holzner E; Fiegl H; Marth C; Wolf D; Pesta M; Hatina J
    Neoplasma; 2012; 59(6):747-55. PubMed ID: 22862176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer stem cells: The root of resistance.
    MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
    Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell markers: premises and prospects.
    Murar M; Vaidya A
    Biomark Med; 2015; 9(12):1331-42. PubMed ID: 26612591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of stem cell markers and signal transducer and activator of transcription 6 (STAT6) in solitary fibrous tumors.
    Wang C; Qi Y; Liu R; Lan J; Zhou Y; Ju X; Chen D; Zou H; Li S; Hu J; Zhao J; Shen Y; Sun Z; Pang L; Li F
    Int J Clin Exp Pathol; 2015; 8(9):10585-94. PubMed ID: 26617768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cancer stem-like cells in chordoma.
    Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
    J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells.
    Soltysova A; Altanerova V; Altaner C
    Neoplasma; 2005; 52(6):435-40. PubMed ID: 16284686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.
    Hope KJ; Jin L; Dick JE
    Nat Immunol; 2004 Jul; 5(7):738-43. PubMed ID: 15170211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.